RecallDepth
Class II Terminated

Losartan Potassium Tablets USP 100 mg, supplied in a) 30 count (NDC 23155-646-03, b) 90 count (NDC 23155-646-09) and 1000 count (NDC 23155-646-10) bottles, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Tamil Nadu, India Manufactured for: Heritage Pharmaceutical Inc., East Brunswick, NJ 08816

This recall has been terminated (originally issued April 15, 2020).

Company
Avet Pharmaceuticals, Inc.
Recall Initiated
March 26, 2020
Posted
April 15, 2020
Recall Number
D-1104-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 12,168; b) 17,196; c) 3,890
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level

Distribution

Nationwide

Lot / Code Info

a) CL018022B, exp Apr 2020 b) CL018010A Mar 2020; CL018017B, CL018018A exp Apr 2020 c) CL018011A, CL018012A exp Mar 2020; CL018013A, CL018015A, CL018016A, CL018017A, exp Apr 2020

More recalls by Avet Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls